Dan Grimes
Senior Vice President
Professional Experience
Associated Office
Early in his career Dan had the unique opportunity to participate in complex, multi-billion-dollar financial transactions through his work in the Corporate Investments Group at Bank of America, where he helped guide the reduction of the bank’s debt and foreign currency exposure through strategic balance sheet hedges. This experience helped shape the foundation for the innovative and analytical approach Dan employs to effectively advise on real estate investments.
Dan lives in Washington, D.C. with his wife, Sophia, and his son, Jordan, and is a proud alumnus of the 1981, 2016 & 2018 National Champions, Clemson University!
Education
- Bachelor degree in Science, Financial Management from Clemson University
Awards
- Connect CRE 2022 Next Generation Award
Significant Transactions
- Brookfield Properties/Douglas Development
655 New York Avenue
$494M - JBG Smith / CPPIB
1900 N St NW
$265M - Boston Properties
New Dominion
$256M - Gannett
USA Today Towers
$207M - Beacon / CALSTRS / GIC
Raytheon Campus
$186.1M - Gramercy Property Trust
Pacific Corporate Park
$145.5M - Steuart Investment Co.
Westfax
$145.1M
- Beacon Capital Partners
Greensboro Park
$142M - Beacon Capital Partners
FINRA Campus
$128M - New York Life/Carr Properties
Centerpointe I & II
$127M - Verizon
Verizon Campus
$122.4M - Lantian Development
Shady Grove Bio + Tech
$116.5M - JBG Smith
Commerce Metro Center
$115M
Representative Sample of Clients Represented
- American Real Estate Partners
- Angelo Gordon
- Atlantic Realty Partners
- Beacon Capital Partners
- Boston Properties
- Brookfield Properties
- CALSTRS
- Carr Properties
- CPPIB
- Douglas Development
- Gannett
- Investcorp
- JBG Smith
- Lantian Development
- MRP
- New York Life
- Rockport
- Steuart Investment Co.
- Tamares
- The Meridian Group
- Trammell Crow
- VEREIT
- Verizon
- Vornado
Led by Tommy Cleaver, CBRE’s Mid Atlantic Office Sales team advises on dispositions, recapitalizations, joint ventures, development, conversions, and capital stack restructurings.
Comprised of a curated group of subject matter experts, the market-leading team has the highest transaction volume within the region since 2020, which marked an inflection point that transformed execution within the office asset class.
Each team member has spent time within the leasing and consulting disciplines which yields a differentiated approach that is consistently recognized by successful outcomes and more importantly, within client testimonials.
The team sources capital at the asset, portfolio, and platform levels for institutional investors as well as generational families and high net worth individuals with bespoke solutions that protect long term interests.
They also frequently partner with CBRE’s occupier account teams to advise on acquisition and disposition strategies for Fortune 500 and non-profit organizations.
The team leverages proprietary data on local and global trends to shape their processes and drive substantiated investment theses. This data is brought to life through the team’s utilization of cutting- edge technology, which is widely recognized as the most innovative in the business.
They are a conduit to CBRE’s debt and structured finance platform and play an instrumental role in sourcing mezzanine and preferred equity capital.
Office Team
Tom Traynor, CFA
Vice Chairman | Co-Head of U.S. Large Loans
Tom Rugg
Vice Chair, Co-Head of U.S. Large Loans
CBRE’s Mid Atlantic Life Sciences team enjoys dominant market share across the capital markets, agency leasing, and occupier disciplines.
The real time insight, gleaned from an unrivaled number of engagements with pharmaceutical, biotech, genomic, contract research, and contract manufacturing organizations produces a market intelligence advantage within an opaque asset class. Simply put, we see things others can’t.
Buttressed by an industry-leading life sciences platform, the team is largely comprised of professionals that have spent their entire careers working solely within biotech verticals including substantial experience on the principal side of the industry.
This deep bench of technical expertise translates to superior guidance on the best ways to meet the user demands of today, from incubation all the way to big pharma, and how to attract specialized talent.
The team leverages proprietary data on a local and global basis to tailor their insights and arm their clients with conclusions that enable effective decisions. This data is brought to life through the team’s utilization of cutting-edge technology, which is widely recognized as the most innovative in the business.
